A caring, diagnosis-led program for patients and families
Stem cell therapy for Alzheimer's disease in Istanbul, Turkey
How our Istanbul memory-care team confirms your diagnosis, protects standard treatment, and offers honest, well-supervised cell therapy support.
Condition-specific editorial anatomy. Explanatory labels remain in accessible text.
Evidence position
What is known, what is investigational, and what is not demonstrated
Careful, evidence-aware supportive program
We screen for treatable contributors to cognitive symptoms — medication, mood, sleep, metabolic, and sensory issues — before anything else.
We explain what each route can realistically do
Anti-amyloid medicines are separate from cell therapies, and we keep your specialist eligibility and monitoring intact.
We match claims to the product
Results vary between patients and stem cell therapy is not a guaranteed cure — we are honest about this from your first consultation.
Direct answer
What the current evidence says
Our physicians start with a confirmed dementia diagnosis, your current treatment, and your family's goals before discussing any cell therapy option. Early human research on specific products is encouraging enough to keep studying, but it does not support promises of memory reversal, and we won't make any. What we offer is a carefully supervised, transparently explained program built around your safety and comfort. Request your free medical evaluation to talk it through with our team.
Clinical map
Start with the diagnosis, stage, and treatment context
We begin every review with a verified dementia diagnosis, your standard treatment, and your caregivers' goals before naming any product.
Established care comes first
- Memory-clinic evaluation: We rely on informant history, cognitive and functional testing, examination, MRI, and targeted labs.
- Evidence-based treatment: We keep cholinesterase inhibitors, memantine, and any eligible disease-modifying options active during your program.
- Daily-life support: Sleep, hearing, vision, exercise, safety, and caregiver wellbeing are all part of your Istanbul plan.
- 01
Syndrome
We help clarify mild cognitive impairment, Alzheimer's dementia, mixed dementia, or another cause with your treating specialist.
- 02
Biologic confirmation
When appropriate, amyloid and tau biomarkers, MRI, and blood or CSF testing sharpen your diagnosis and options.
- 03
Stage and support
We plan around function, behavior, medication safety, caregiver capacity, and comfort — not just a test score.
Evidence ledger
Read the actual study, including the result that did not change
Each row keeps product identity, route, endpoint, and limitation together so one trial cannot become a generic treatment claim.
01 Allogeneic bone marrow MSC phase 1 study
Open source- Product
- Single allogeneic bone marrow-derived MSC product
- Route
- Intravenous infusion
- Design
- Small randomized, placebo-controlled, dose-escalation trial
- Finding
- The study primarily supported short-term safety and feasibility assessment, not clinical efficacy.
- Limitation
- Small sample, early phase, exploratory biomarkers, and no basis for claims of cognitive improvement or disease slowing.
Product and route
A mechanism is not a clinical outcome
- 01
We explain what each route can realistically do
Intravenous, intrathecal, and intranasal delivery differ in biodistribution and risk, and we walk you through the honest limits of each.
BoundaryEvidence applies only to the studied product, population, dose, route, comparator, and endpoint.
- 02
We match claims to the product
Bone marrow MSCs, cord MSCs, and exosomes are different products, and your evaluation names exactly which one is being proposed.
BoundaryEvidence applies only to the studied product, population, dose, route, comparator, and endpoint.
Outcomes before travel
Decide what meaningful change would look like
A baseline and a time point matter more than an isolated testimonial. These measures should be chosen before any intervention.
- 01
Validated cognition scale
- 02
Instrumental and basic daily function
- 03
Neuropsychiatric symptoms and caregiver burden
- 04
Falls, hospitalization, and medication effects
- 05
Biomarkers only when clinically justified
Specialist review
What a complete Istanbul review needs
How our Istanbul memory-care team confirms your diagnosis, protects standard treatment, and offers honest, well-supervised cell therapy support.
Records and baseline
- Memory specialist diagnosis and stage
- MRI and biomarker reports when available
- Medication list, sleep, hearing, mood, and vascular risk
- Baseline cognitive and daily-function measures
- Caregiver availability, consent capacity, and travel tolerance
Safety and planning checks
- We never ask you to pause dementia medicines or a diagnostic pathway for an experimental option.
- Your Istanbul plan names who can consent, who accompanies the patient, and how any change in behavior will be handled.
- We track outcomes that matter to your daily life, not isolated lab markers.
Transparent planning
Build the medical plan before the package
A quote should follow record review, product disclosure, route rationale, and a written follow-up plan. This page does not invent a universal price.
- We never ask you to pause dementia medicines or a diagnostic pathway for an experimental option.
- Your Istanbul plan names who can consent, who accompanies the patient, and how any change in behavior will be handled.
- We track outcomes that matter to your daily life, not isolated lab markers.
Questions the plan must answer
- 01
We explain what each route can realistically do: Intravenous, intrathecal, and intranasal delivery differ in biodistribution and risk, and we walk you through the honest limits of each.
- 02
We match claims to the product: Bone marrow MSCs, cord MSCs, and exosomes are different products, and your evaluation names exactly which one is being proposed.
Primary reading
Guidelines, trials, and regulatory context
FAQ
Questions patients ask before an Istanbul review
Request Medical Evaluation
Begin a personalized treatment conversation with our medical team.
Share your case in confidence. Our international coordinators review every enquiry and respond within 24 hours, in your language.